Related Experiment Video
Updated: Dec 6, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Generation of virtual patient data for in-silico cardiomyopathies drug development using tree ensembles: a
Abstract:
In-silico clinical platforms have been recently used as a new revolutionary path for virtual patients (VP) generation and further analysis, such as, drug development. Advanced individualized models have been developed to enhance flexibility and reliability of the virtual patient cohorts. This study focuses on the implementation and comparison of three different methodologies for generating virtual data for in-silico clinical trials. Towards this direction, three computational methods, namely: (i) the multivariate log-normal distribution (log- MVND), (ii) the supervised tree ensembles, and (iii) the unsupervised tree ensembles are deployed and evaluated against their performance towards the generation of high-quality virtual data using the goodness of fit (gof) and the dataset correlation matrix as performance evaluation measures. Our results reveal the dominance of the tree ensembles towards the generation of virtual data with similar distributions (gof values less than 0.2) and correlation patterns (average difference less than 0.03).
More Related Videos
08:06Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization
Published on: January 17, 2020
13:18Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells
Published on: June 28, 2013
Related Concept Videos
EPS and iPS Cells in Disease Research
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification